-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, F871sYXhkfc/HdaFBXBWz8JDNgfGPdH8Yqk0Y8qgpczC+nQm4kTkSkhtQIgAS4nP Knuf02zVIoGj945EmimawA== 0001116502-03-000568.txt : 20030401 0001116502-03-000568.hdr.sgml : 20030401 20030401124028 ACCESSION NUMBER: 0001116502-03-000568 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20030317 ITEM INFORMATION: Change in fiscal year FILED AS OF DATE: 20030401 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP CENTRAL INDEX KEY: 0000875622 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113054851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-19879 FILM NUMBER: 03633398 BUSINESS ADDRESS: STREET 1: 35 WILBUR ST CITY: LYNBROOK STATE: NY ZIP: 11563 BUSINESS PHONE: 5165937000 MAIL ADDRESS: STREET 1: 35 WILBUR STREET CITY: LYNBROOK STATE: NY ZIP: 11563 8-K 1 biospecifics-8k.txt CURRENT REPORT SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 17, 2003 BioSpecifics Technologies Corp. (Exact name of registrant as specified in its charter) Delaware File No. 0-19879 11-3054851 (State of incorporation) (Commission File Number) (IRS Employer Identification No.) 35 Wilbur Street, Lynbrook, New York 11563 (Address of principal executive offices) (zip code) Registrant's telephone number, including area code: (516) 593-7000 Item 8. Change in Fiscal Year On March 17, 2003, the Board of Directors of BioSpecifics Technologies Corp. (the "Corporation") authorized changing the Corporation's fiscal year end from January 31 to a calendar year end, or December 31. The Corporation's final report using the fiscal year ended January 31 will be on Form 10-KSB for the fiscal year ended January 31, 2003. The change becomes effective for the fiscal year ended December 31, 2003, and the Corporation's first report using the new fiscal year will be on Form 10-QSB for the three months ended March 31, 2003. -2- SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. BIOSPECIFICS TECHNOLOGIES CORP. Dated: April 1, 2003 By: /s/ Albert Horcher ------------------------------------ Name: Albert Horcher Title: Principal Accounting Officer -3- -----END PRIVACY-ENHANCED MESSAGE-----